Tycho Peterson
Stock Analyst at Jefferies
(5.00)
# 4
Out of 5,182 analysts
136
Total ratings
64.71%
Success rate
147.88%
Average return
Main Sectors:
Stocks Rated by Tycho Peterson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Initiates: Underperform | $35 | $52.68 | -33.56% | 1 | Apr 13, 2026 | |
| VCYT Veracyte | Initiates: Buy | $45 | $33.85 | +32.94% | 1 | Apr 13, 2026 | |
| CAI Caris Life Sciences | Initiates: Buy | $28 | $19.93 | +40.49% | 1 | Apr 13, 2026 | |
| MTD Mettler-Toledo International | Upgrades: Buy | $1,400 → $1,450 | $1,274.70 | +13.75% | 9 | Mar 20, 2026 | |
| DGX Quest Diagnostics | Maintains: Buy | $215 → $220 | $196.63 | +11.89% | 4 | Feb 11, 2026 | |
| RVTY Revvity | Maintains: Hold | $100 → $105 | $86.80 | +20.97% | 2 | Feb 3, 2026 | |
| DHR Danaher | Maintains: Overweight | $270 → $275 | $180.62 | +52.25% | 5 | Jan 29, 2026 | |
| AVTR Avantor | Downgrades: Underperform | $12 → $9 | $7.97 | +12.92% | 1 | Dec 17, 2025 | |
| BLLN BillionToOne | Initiates: Hold | $117 | $81.76 | +43.10% | 1 | Dec 1, 2025 | |
| WAT Waters | Maintains: Buy | $435 → $385 | $299.79 | +28.42% | 8 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $160 → $155 | $115.62 | +34.06% | 8 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $80 | $66.17 | +20.90% | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $44 | $12.29 | +258.01% | 6 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $275 → $290 | $263.43 | +10.09% | 2 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $22 | $8.61 | +155.52% | 1 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $41 → $53 | $38.09 | +39.07% | 5 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $28 → $35 | $61.00 | -42.62% | 3 | Aug 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $24 | $22.28 | +7.72% | 7 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $1.59 | +151.57% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $5 → $3 | $2.57 | +16.73% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $142 | $204.39 | -30.52% | 3 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $88.50 | -63.84% | 2 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Hold | $115 | $128.52 | -10.52% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Underperform | $25 → $20 | $4.83 | +314.08% | 1 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $600 → $650 | $468.04 | +38.88% | 12 | Jun 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $26 → $9 | $15.81 | -43.07% | 1 | Sep 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.36 | - | 2 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $20 → $12 | $1.95 | +515.38% | 2 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $60 | $3.21 | +1,769.16% | 2 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $23 | $4.86 | +373.25% | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $375 → $390 | $171.23 | +127.76% | 5 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $18 | $3.01 | +498.01% | 1 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $188 → $200 | $470.99 | -57.54% | 9 | Jun 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $22 → $24 | $26.77 | -10.35% | 3 | Jun 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $65 → $45 | $11.96 | +276.25% | 5 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $70 | $118.29 | -40.82% | 2 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $120 | $163.84 | -26.76% | 1 | Feb 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $0.44 | - | 7 | Dec 13, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $36.53 | - | 5 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $55 | $9.01 | +510.43% | 1 | Jul 19, 2016 |
Tempus AI
Apr 13, 2026
Initiates: Underperform
Price Target: $35
Current: $52.68
Upside: -33.56%
Veracyte
Apr 13, 2026
Initiates: Buy
Price Target: $45
Current: $33.85
Upside: +32.94%
Caris Life Sciences
Apr 13, 2026
Initiates: Buy
Price Target: $28
Current: $19.93
Upside: +40.49%
Mettler-Toledo International
Mar 20, 2026
Upgrades: Buy
Price Target: $1,400 → $1,450
Current: $1,274.70
Upside: +13.75%
Quest Diagnostics
Feb 11, 2026
Maintains: Buy
Price Target: $215 → $220
Current: $196.63
Upside: +11.89%
Revvity
Feb 3, 2026
Maintains: Hold
Price Target: $100 → $105
Current: $86.80
Upside: +20.97%
Danaher
Jan 29, 2026
Maintains: Overweight
Price Target: $270 → $275
Current: $180.62
Upside: +52.25%
Avantor
Dec 17, 2025
Downgrades: Underperform
Price Target: $12 → $9
Current: $7.97
Upside: +12.92%
BillionToOne
Dec 1, 2025
Initiates: Hold
Price Target: $117
Current: $81.76
Upside: +43.10%
Waters
Aug 4, 2025
Maintains: Buy
Price Target: $435 → $385
Current: $299.79
Upside: +28.42%
May 29, 2025
Maintains: Overweight
Price Target: $160 → $155
Current: $115.62
Upside: +34.06%
May 9, 2025
Upgrades: Buy
Price Target: $80
Current: $66.17
Upside: +20.90%
May 8, 2025
Upgrades: Buy
Price Target: $44
Current: $12.29
Upside: +258.01%
Feb 6, 2025
Maintains: Buy
Price Target: $275 → $290
Current: $263.43
Upside: +10.09%
Dec 10, 2024
Initiates: Buy
Price Target: $22
Current: $8.61
Upside: +155.52%
Dec 10, 2024
Assumes: Buy
Price Target: $41 → $53
Current: $38.09
Upside: +39.07%
Aug 5, 2024
Maintains: Underweight
Price Target: $28 → $35
Current: $61.00
Upside: -42.62%
Jul 22, 2024
Upgrades: Buy
Price Target: $24
Current: $22.28
Upside: +7.72%
Jun 3, 2024
Initiates: Buy
Price Target: $4
Current: $1.59
Upside: +151.57%
Jun 3, 2024
Assumes: Hold
Price Target: $5 → $3
Current: $2.57
Upside: +16.73%
Jun 3, 2024
Initiates: Buy
Price Target: $142
Current: $204.39
Upside: -30.52%
Jun 3, 2024
Initiates: Buy
Price Target: $32
Current: $88.50
Upside: -63.84%
Jun 3, 2024
Assumes: Hold
Price Target: $115
Current: $128.52
Upside: -10.52%
Jun 3, 2024
Assumes: Underperform
Price Target: $25 → $20
Current: $4.83
Upside: +314.08%
Jun 3, 2024
Assumes: Buy
Price Target: $600 → $650
Current: $468.04
Upside: +38.88%
Sep 21, 2022
Downgrades: Underweight
Price Target: $26 → $9
Current: $15.81
Upside: -43.07%
Aug 16, 2022
Downgrades: Neutral
Price Target: n/a
Current: $2.36
Upside: -
Aug 11, 2022
Downgrades: Neutral
Price Target: $20 → $12
Current: $1.95
Upside: +515.38%
Mar 2, 2022
Maintains: Overweight
Price Target: $85 → $60
Current: $3.21
Upside: +1,769.16%
Aug 17, 2021
Initiates: Overweight
Price Target: $23
Current: $4.86
Upside: +373.25%
May 28, 2021
Maintains: Overweight
Price Target: $375 → $390
Current: $171.23
Upside: +127.76%
Aug 10, 2020
Initiates: Neutral
Price Target: $18
Current: $3.01
Upside: +498.01%
Jun 18, 2020
Maintains: Overweight
Price Target: $188 → $200
Current: $470.99
Upside: -57.54%
Jun 1, 2020
Maintains: Overweight
Price Target: $22 → $24
Current: $26.77
Upside: -10.35%
Mar 17, 2020
Maintains: Neutral
Price Target: $65 → $45
Current: $11.96
Upside: +276.25%
Nov 2, 2018
Maintains: Overweight
Price Target: $60 → $70
Current: $118.29
Upside: -40.82%
Feb 15, 2018
Maintains: Overweight
Price Target: $115 → $120
Current: $163.84
Upside: -26.76%
Dec 13, 2017
Downgrades: Underweight
Price Target: n/a
Current: $0.44
Upside: -
Nov 3, 2017
Downgrades: Neutral
Price Target: n/a
Current: $36.53
Upside: -
Jul 19, 2016
Initiates: Neutral
Price Target: $55
Current: $9.01
Upside: +510.43%